☆ 3.8 Review

Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach

NEUROLOGY INTERNATIONAL (2022)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study

Gabriel Bsteh et al.

Summary: This study compared the humoral immune response and safety of SARS-CoV-2 vaccines in patients with multiple sclerosis (pwMS) and healthy controls (HCs). The results showed that the majority of pwMS had seroconversion, but the immune response was reduced by immunosuppressive disease-modifying treatments (DMTs).

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica

Edouard Januel et al.

Summary: Recent studies suggest a lower anti-spike protein-based immunoglobulin-G response following COVID-19 vaccination in patients treated with anti-CD20 and fingolimod. This study evaluated cases of COVID-19 occurring after vaccination among patients with MS and NMO, finding mild severity in cases reported. The results emphasize the need for a third COVID-19 vaccine dose for anti-CD20 treated patients and call for further prospective studies on vaccine efficacy in MS and NMO patients.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Article Clinical Neurology

Humoral- and T-Cell Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies

Carla Tortorella et al.

Summary: This study evaluated the immune-specific response after full SARS-CoV-2 vaccination in patients with multiple sclerosis (MS) treated with different disease-modifying drugs. The results showed that mRNA vaccines induced both humoral and cell-mediated specific immune responses against viral spike proteins in the majority of patients with MS. These findings have important implications for promoting vaccination in all MS patients.

NEUROLOGY (2022)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Longitudinal Analysis Suggests Epstein--Barr as Cause of Multiple Sclerosis

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Clinical Neurology

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis

Ana Zabalza et al.

Summary: This study investigated the humoral and cellular responses to SARS-CoV-2 in convalescent COVID-19 patients with multiple sclerosis (PwMS) and explored factors influencing the persistence of these immune responses. The results showed that both humoral and cellular responses can persist for several months in convalescent patients, but they are influenced by treatment methods and disease characteristics.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Add to Collection

Article Medicine, General & Internal

Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases

Giulia Bivona et al.

Summary: Vitamin D is a steroid hormone that plays a crucial role in regulating calcium-phosphorus homeostasis, immune response, and brain function. Studies have shown that low serum levels of 25-hydroxyvitamin D (25(OH)D), which is considered a biomarker for Vitamin D status, are associated with neurological, psychiatric, and autoimmune diseases. However, there is still uncertainty about whether serum 25(OH)D measurement can be a clinically useful biomarker for diagnosing, prognosing, and predicting treatment response in these conditions due to the lack of standardized data and discrepancies among studies.

DIAGNOSTICS (2022)

Add to Collection

Article Clinical Neurology

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey

Emilio Portaccio et al.

Summary: The survey conducted by ECTRIMS showed the impact of COVID-19 emergency on access to care for PwMS and on MS treatment practices, with telemedicine playing a crucial role in overcoming limited access to care. Gathering data on DMT safety remains crucial for informing treatment decisions.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Article Clinical Neurology

Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies

Luca Prosperini et al.

Summary: The pooled analysis indicates a 24% increased risk of death from COVID-19 in patients with multiple sclerosis. However, confirmation in larger population-based studies is needed due to difficulties in COVID-19 case detection and cohort heterogeneity.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Letter Clinical Neurology

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis

Massimiliano Di Filippo et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Add to Collection

Article Clinical Neurology

Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years

Emilio Portaccio et al.

Summary: This study assessed the impact of timing of natalizumab cessation/redosing on long-term maternal and infant outcomes in multiple sclerosis (MS) pregnancies. The results showed that the conservative approach was the only predictor of relapse occurrence, and the treatment approach reduced the risk of disease activity.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Article Multidisciplinary Sciences

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Kjetil Bjornevik et al.

Summary: This study suggests that multiple sclerosis may be caused by Epstein-Barr virus, with no direct association with other viral infections. These findings provide clues to the primary cause of MS.

SCIENCE (2022)

Add to Collection

Letter Critical Care Medicine

COVID-19 mortality and health-care resources: Organization

P. Immovilli et al.

MEDICINA INTENSIVA (2021)

Add to Collection

Article Clinical Neurology

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Maria P. Sormani et al.

Summary: This study assessed the impact of immunosuppressive and immunomodulatory therapies on the severity of COVID-19 in people with multiple sclerosis. Therapy with an anti-CD20 agent and recent use of methylprednisolone were associated with increased risk of severe COVID-19.

ANNALS OF NEUROLOGY (2021)

Add to Collection

Article Psychiatry

Psycho-social factors associated with mental resilience in the Corona lockdown

Ilya M. Veer et al.

Summary: The study explored factors that influence psychological resilience, including positive appraisal style, perceived social support, and the ability to recover from stress. The findings indicated that positive appraisal and stress response recovery were the most important resilience factors, which can be targeted in mental health interventions. This research identifies modifiable protective factors that generalize across major socio-demographic categories.

TRANSLATIONAL PSYCHIATRY (2021)

Add to Collection

Meeting Abstract Clinical Neurology

Increased risk of death from COVID-19 in multiple sclerosis: A meta-analysis of observational studies

Luca Prosperini et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Salim S. Abdool Karim et al.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

The physiological correlates of interpersonal space

Michela Candini et al.

Summary: Interpersonal space refers to the area individuals maintain between themselves and others during social interactions. Research has shown that skin conductance response increases when individuals are exposed to closeness of an unknown person, suggesting a functional link between behavioral components of IPS regulation and underlying physiological processes.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Clinical Neurology

Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases

Riccardo Nistri et al.

Summary: This study described a temporal association between COVID-19 vaccination and MS relapses in 16 patients, with 3 patients experiencing their first episode post-vaccination and 13 already diagnosed with MS. All relapses occurred 3 days to 3 weeks after vaccination, with evidence of radiological activity on MRI in all patients. The nature of this association, whether causal or incidental, remains to be determined.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Anat Achiron et al.

Summary: The study shows that the COVID-19 BNT162b2 vaccine is safe for patients with MS, with no increased risk of relapse activity observed after vaccination.

MULTIPLE SCLEROSIS JOURNAL (2021)

Add to Collection

Article Clinical Neurology

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis

Amber Salter et al.

Summary: This study examined outcomes and risk factors associated with COVID-19 clinical severity in a large, diverse cohort of North American patients with multiple sclerosis. The study found that ambulatory disability, older age, male sex, Black race, cardiovascular comorbidities, and recent corticosteroid use were associated with increased odds of worse clinical severity in MS patients with COVID-19. Knowledge of these risk factors may help improve the treatment and monitoring of these patients.

JAMA NEUROLOGY (2021)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Editorial of Special Issue Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry

Masaru Tanaka et al.

BIOMEDICINES (2021)

Add to Collection

Article Clinical Neurology

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

Mike P. Wattjes et al.

Summary: The 2021 revision of guidelines on MRI use for multiple sclerosis patients integrates recommendations from various organizations to improve the application of MRI for diagnosis, prognosis, and monitoring of individuals with multiple sclerosis. It suggests changes in MRI acquisition protocols, cautious use of gadolinium-based contrast agents, and extends recommendations to the use of MRI in children, during pregnancy, and in the post-partum period for patients with multiple sclerosis.

LANCET NEUROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

Sokratis A. Apostolidis et al.

Summary: Patients with multiple sclerosis on anti-CD20 monotherapy exhibit significantly reduced SARS-CoV-2-specific antibodies and memory B cells, while CD4(+) and CD8(+) T cells are robustly activated compared to healthy controls after receiving BNT162b2 or mRNA-1273 mRNA vaccination.

NATURE MEDICINE (2021)

Add to Collection

Article Clinical Neurology

DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France

Maria Pia Sormani et al.

Summary: This study evaluated the impact of disease-modifying therapies on Covid-19 severity in patients with multiple sclerosis through a pooled-analysis of two large cohorts. The results showed that anti-CD20 therapies were significantly associated with severe Covid-19, while interferon indicated a decreased risk.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

Maria Pia Sormani et al.

Summary: This study found that anti-CD20 treatment and fingolimod in MS patients led to reduced humoral response to mRNA vaccines. mRNA-1273 vaccine resulted in significantly higher antibody levels compared to BNT162b2, suggesting it may be preferred for patients under certain treatments.

EBIOMEDICINE (2021)

Add to Collection

Article Clinical Neurology

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection

Antonia Pignolo et al.

Summary: SARS-CoV-2 infection may trigger the onset or relapse of multiple sclerosis, with serum IgG testing showing antibody seroconversion but not necessarily providing full protection against reinfection. Therefore, the importance of vaccination for individuals with MS is underscored.

NEUROLOGY INTERNATIONAL (2021)

Add to Collection

Article Clinical Neurology

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Anat Achiron et al.

Summary: The study found that after receiving the COVID-19 vaccine, MS patients who were either untreated or treated with cladribine showed a high level of protective humoral immunity, similar to healthy subjects. However, only a small percentage of MS patients treated with ocrelizumab and fingolimod developed a humoral immune response.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)

Add to Collection

Article Clinical Neurology

Precision medicine in the multiple sclerosis clinic: Selecting the right patient for the right treatment

Gauruv Bose et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Add to Collection

Editorial Material Clinical Neurology

The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack

Nicola Morelli et al.

EUROPEAN NEUROLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Treatment of Multiple Sclerosis: A Review

Stephen L. Hauser et al.

AMERICAN JOURNAL OF MEDICINE (2020)

Add to Collection

Article Neurosciences

The spatial effect of fearful faces in the autonomic response

Giulia Ellena et al.

EXPERIMENTAL BRAIN RESEARCH (2020)

Add to Collection

Article Clinical Neurology

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Celine Louapre et al.

JAMA NEUROLOGY (2020)

Add to Collection

Letter Clinical Neurology

Stroke in COVID-19 patients-A case series from Italy

Paolo Immovilli et al.

INTERNATIONAL JOURNAL OF STROKE (2020)

Add to Collection

Article Clinical Neurology

COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation

Duraisamy Kempuraj et al.

NEUROSCIENTIST (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Monitoring the Redox Status in Multiple Sclerosis

Masaru Tanaka et al.

BIOMEDICINES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway

Nora Torok et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Letter Critical Care Medicine

COVID-19 mortality and ICU admission: the Italian experience

Paolo Immovilli et al.

CRITICAL CARE (2020)

Add to Collection

Review Clinical Neurology

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

Massimo Filippi et al.

BRAIN (2019)

Add to Collection

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Add to Collection

Article Clinical Neurology

Anti-JC Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Tatiana Plavina et al.

ANNALS OF NEUROLOGY (2014)

Add to Collection

Article Clinical Neurology

Epidemiology of Multiple Sclerosis

Sreeram V. Ramagopalan et al.

NEUROLOGIC CLINICS (2011)

Add to Collection

Review Information Science & Library Science

A typology of reviews: an analysis of 14 review types and associated methodologies

Maria J. Grant et al.

HEALTH INFORMATION AND LIBRARIES JOURNAL (2009)

Add to Collection

Review Medicine, General & Internal

Medical progress: Multiple sclerosis.

JH Noseworthy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.